SCHEMBL3842628

SCHEMBL3842628

O=C(O)c1cc(-c2ccccc2)c2cc3n(c2c1)C(O)c1ccccc1-3

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.37
KDM4A O75164 1/20 0.36
KDM4B O94953 1/20 0.36
KDM4D Q6B0I6 1/20 0.36
KDM4C Q9H3R0 1/20 0.36
TTR P02766 4/20 0.36
P2RY14 Q15391 1/20 0.36
PTPRC P08575 2/20 0.35
POLB P06746 2/20 0.34
KMT2A Q03164 1/20 0.34
KDM4E B2RXH2 1/20 0.33
ALOX15 P16050 1/20 0.33
RXRA P19793 1/20 0.33
RXRB P28702 1/20 0.33
RXRG P48443 1/20 0.33
SCN9A Q15858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL772512 0.75 ALDH1A1 (0.37) ALDH1A1TTRPTPRCPOLBKMT2A
SCHEMBL5312887 0.71 ALDH1A1 (0.38) ALDH1A1KDM4AKDM4BKDM4DKDM4C
SCHEMBL10988314 0.64 MEN1 (0.59) ALDH1A1KDM4AKDM4BKDM4DKDM4C
SCHEMBL29279320 0.63 PTPN1 (0.58) ALDH1A1KDM4AKDM4BKDM4DKDM4C
SCHEMBL10900757 0.62 GRIN2D (0.53) ALDH1A1KDM4AKDM4BKDM4DKDM4C
SCHEMBL30184435 0.60 HTR2B (0.61) ALDH1A1TTRPTPRCPOLBKMT2A
SCHEMBL7596515 0.60 XDH (0.44) KDM4AKDM4BKDM4DKDM4CP2RY14
SCHEMBL9301722 0.60 P2RY14 (0.63) ALDH1A1KDM4AKDM4BKDM4DKDM4C
SCHEMBL10578274 0.60 XDH (0.44) ALDH1A1KDM4AKDM4BKDM4DKDM4C
SCHEMBL27972376 0.60 ALDH1A1 (0.44) ALDH1A1TTRPOLBKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2114947-A1 INDOLOBENZAZEPINE DERIVATIVES FOR THE TREATMENT OF HEPATITIS C Brystol-Myers Squibb Company (US) 2009-11-11 EP disclosed
EP-2099804-A1 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C Brystol-Myers Squibb Company (US) 2009-09-16 EP disclosed
WO-2008097796-A1 INDOLOBENZAZEPINE DERIVATIVES FOR THE TREATMENT OF HEPATITIS C BRISTOL-MYERS SQUIBB COMPANY (US) 2008-08-14 WO disclosed
WO-2008089027-A1 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C BRISTOL-MYERS SQUIBB COMPANY (US) 2008-07-24 WO disclosed
WO-2007033032-A1 CYCLOPROPYL FUSED INDOLOBENZAZEPINE HCV NS5B INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-03-22 WO disclosed
WO-2007033175-A1 INDOLOBENZAZEPINE HCV NS5B INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-03-22 WO disclosed